Role of Pulmonary Vasodilators in Ameliorating Primary Graft Dysfunction Following Lung Transplant
JAMA Surg
.
2022 Jan 1;157(1):e215857.
doi: 10.1001/jamasurg.2021.5857.
Epub 2022 Jan 12.
Authors
Emily Cerier
1
,
Kalvin Lung
1
,
Ankit Bharat
1
Affiliation
1
Division of Thoracic Surgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.
PMID:
34787654
PMCID:
PMC8980734
DOI:
10.1001/jamasurg.2021.5857
No abstract available
Publication types
Comment
MeSH terms
Humans
Lung Transplantation* / adverse effects
Primary Graft Dysfunction*
Risk Factors
Vasodilator Agents / therapeutic use
Substances
Vasodilator Agents
Grants and funding
R01 HL145478/HL/NHLBI NIH HHS/United States
T32 AI083216/AI/NIAID NIH HHS/United States